Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

Clinical Trial ID NCT00269412

PubWeight™ 2.17^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00269412

Top papers